MXPA02012205A - Inhibidores de transcriptasa inversa no nucleosidos. - Google Patents

Inhibidores de transcriptasa inversa no nucleosidos.

Info

Publication number: MXPA02012205A
Authority: MX; Mexico
Prior art keywords: reverse transcriptase; transcriptase inhibitors; nucleoside reverse; group; inhibitors
Prior art date: 2000-06-16

Application number

MXPA02012205A

Other languages

English (en)

Inventor

Bruno Simoneau

Original Assignee

Boehringer Ingelheim Ca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-16

Filing date

2001-06-14

Publication date

2003-09-10

2001-06-14 Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd

2003-09-10 Publication of MXPA02012205A publication Critical patent/MXPA02012205A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Steroid Compounds (AREA)

MXPA02012205A 2000-06-16 2001-06-14 Inhibidores de transcriptasa inversa no nucleosidos. MXPA02012205A (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US21232900P	2000-06-16	2000-06-16
US25663800P	2000-12-18	2000-12-18
PCT/CA2001/000890 WO2001096338A1 (en)	2000-06-16	2001-06-14	Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number	Publication Date
MXPA02012205A true MXPA02012205A (es)	2003-09-10

Family

ID=26907019

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA02012205A MXPA02012205A (es)	2000-06-16	2001-06-14	Inhibidores de transcriptasa inversa no nucleosidos.

Country Status (35)

Country	Link
US (1)	US6420359B1 (es)
EP (1)	EP1294720B1 (es)
JP (1)	JP3923894B2 (es)
KR (1)	KR20030017540A (es)
CN (1)	CN1178939C (es)
AR (1)	AR028958A1 (es)
AT (1)	ATE322492T1 (es)
AU (2)	AU7037001A (es)
BG (1)	BG107348A (es)
BR (1)	BR0102377A (es)
CA (1)	CA2411766C (es)
CZ (1)	CZ20024114A3 (es)
DE (1)	DE60118560T2 (es)
DK (1)	DK1294720T3 (es)
EA (1)	EA005598B1 (es)
EE (1)	EE200200690A (es)
ES (1)	ES2261433T3 (es)
HR (1)	HRP20021003A2 (es)
HU (1)	HUP0301105A2 (es)
IL (1)	IL152819A0 (es)
MX (1)	MXPA02012205A (es)
MY (1)	MY130375A (es)
NO (1)	NO323830B1 (es)
NZ (1)	NZ523549A (es)
PE (1)	PE20020083A1 (es)
PL (1)	PL360370A1 (es)
PT (1)	PT1294720E (es)
SA (1)	SA01220202B1 (es)
SK (1)	SK17722002A3 (es)
TW (1)	TWI270547B (es)
UA (1)	UA74834C2 (es)
UY (1)	UY26767A1 (es)
WO (1)	WO2001096338A1 (es)
YU (1)	YU94202A (es)
ZA (1)	ZA200209807B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6716836B2 (en)	2001-03-22	2004-04-06	Boehringer Ingelheim (Canada) Ltd.	Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en)	2001-07-30	2004-01-06	Boehringer Ingelheim (Canada) Ltd.	Non-nucleoside reverse transcriptase inhibitors
US6706706B2 (en) *	2002-03-27	2004-03-16	Boehringer Ingelheim International Gmbh	Non-nucleoside reverse transcriptase inhibitors
US6806265B2 (en) *	2002-05-16	2004-10-19	Boehringer Ingelheim International Gmbh	Non-nucleoside reverse transcriptase inhibitors
US6759533B2 (en) *	2002-06-28	2004-07-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
US7642277B2 (en)	2002-12-04	2010-01-05	Boehringer Ingelheim International Gmbh	Non-nucleoside reverse transcriptase inhibitors
KR20050085681A (ko) *	2002-12-16	2005-08-29	베링거 인겔하임 인터내셔날 게엠베하	프로테아제 억제제와 같은 사이토크롬 ｐ450의 억제제와함께 비-뉴클레오시드 역전사효소 억제제(ｎｎｒｔｉ)를함유하는 배합물의 용도
EP1610782A1 (en) *	2003-03-27	2006-01-04	Boehringer Ingelheim International GmbH	Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
US7309700B2 (en) *	2004-04-02	2007-12-18	Boehringer Ingelheim International Gmbh	Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one
US20060025480A1 (en)	2004-08-02	2006-02-02	Boehringer Ingelheim International Gmbh	Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors
US7151174B2 (en)	2004-11-05	2006-12-19	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Process for making a non-nucleoside HIV-1 reverse transcriptase inhibitor
US7282583B2 (en) *	2005-12-05	2007-10-16	Boehringer Ingelheim International Gmbh	Process for making 5,11-Dihydro-11-ethyl-5-methyl-8{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one
EP2085390A1 (en) *	2008-01-31	2009-08-05	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
AU2010234241A1 (en) *	2009-04-09	2011-09-08	Boehringer Ingelheim International Gmbh	Inhibitors of HIV replication

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5366972A (en) *	1989-04-20	1994-11-22	Boehringer Ingelheim Pharmaceuticals, Inc.	5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) *	1995-10-06	1998-01-06	Boehringer Ingelheim Pharmaceuticals, Inc.	8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection

2001
- 2001-05-30 TW TW090113049A patent/TWI270547B/zh not_active IP Right Cessation
- 2001-06-12 BR BR0102377-2A patent/BR0102377A/pt not_active IP Right Cessation
- 2001-06-12 US US09/879,447 patent/US6420359B1/en not_active Expired - Lifetime
- 2001-06-13 UY UY26767A patent/UY26767A1/es not_active Application Discontinuation
- 2001-06-14 PT PT01949124T patent/PT1294720E/pt unknown
- 2001-06-14 KR KR1020027017173A patent/KR20030017540A/ko not_active Abandoned
- 2001-06-14 CA CA002411766A patent/CA2411766C/en not_active Expired - Fee Related
- 2001-06-14 NZ NZ523549A patent/NZ523549A/en unknown
- 2001-06-14 PL PL36037001A patent/PL360370A1/xx not_active Application Discontinuation
- 2001-06-14 DK DK01949124T patent/DK1294720T3/da active
- 2001-06-14 ES ES01949124T patent/ES2261433T3/es not_active Expired - Lifetime
- 2001-06-14 EE EEP200200690A patent/EE200200690A/xx unknown
- 2001-06-14 JP JP2002510480A patent/JP3923894B2/ja not_active Expired - Lifetime
- 2001-06-14 DE DE60118560T patent/DE60118560T2/de not_active Expired - Lifetime
- 2001-06-14 WO PCT/CA2001/000890 patent/WO2001096338A1/en active IP Right Grant
- 2001-06-14 AU AU7037001A patent/AU7037001A/xx active Pending
- 2001-06-14 CN CNB018112692A patent/CN1178939C/zh not_active Expired - Fee Related
- 2001-06-14 PE PE2001000560A patent/PE20020083A1/es not_active Application Discontinuation
- 2001-06-14 AT AT01949124T patent/ATE322492T1/de active
- 2001-06-14 IL IL15281901A patent/IL152819A0/xx unknown
- 2001-06-14 AU AU2001270370A patent/AU2001270370B2/en not_active Ceased
- 2001-06-14 HU HU0301105A patent/HUP0301105A2/hu unknown
- 2001-06-14 EA EA200201255A patent/EA005598B1/ru not_active IP Right Cessation
- 2001-06-14 SK SK1772-2002A patent/SK17722002A3/sk not_active Application Discontinuation
- 2001-06-14 MX MXPA02012205A patent/MXPA02012205A/es active IP Right Grant
- 2001-06-14 HR HR20021003A patent/HRP20021003A2/hr not_active Application Discontinuation
- 2001-06-14 EP EP01949124A patent/EP1294720B1/en not_active Expired - Lifetime
- 2001-06-14 CZ CZ20024114A patent/CZ20024114A3/cs unknown
- 2001-06-14 YU YU94202A patent/YU94202A/sh unknown
- 2001-06-14 UA UA2003010387A patent/UA74834C2/uk unknown
- 2001-06-15 AR ARP010102870A patent/AR028958A1/es unknown
- 2001-06-15 MY MYPI20012820A patent/MY130375A/en unknown
- 2001-07-07 SA SA01220202A patent/SA01220202B1/ar unknown
2002
- 2002-12-03 BG BG107348A patent/BG107348A/bg unknown
- 2002-12-03 ZA ZA200209807A patent/ZA200209807B/en unknown
- 2002-12-05 NO NO20025844A patent/NO323830B1/no unknown

Also Published As

Publication number	Publication date
EA005598B1 (ru)	2005-04-28
NZ523549A (en)	2004-08-27
YU94202A (sh)	2005-11-28
CA2411766C (en)	2006-05-23
AU7037001A (en)	2001-12-24
ATE322492T1 (de)	2006-04-15
TWI270547B (en)	2007-01-11
ES2261433T3 (es)	2006-11-16
NO20025844L (no)	2002-12-05
KR20030017540A (ko)	2003-03-03
CZ20024114A3 (cs)	2003-04-16
CN1178939C (zh)	2004-12-08
ZA200209807B (en)	2003-10-16
HUP0301105A2 (hu)	2003-08-28
NO323830B1 (no)	2007-07-09
US6420359B1 (en)	2002-07-16
SA01220202B1 (ar)	2006-09-05
HRP20021003A2 (en)	2005-02-28
BR0102377A (pt)	2002-02-19
EP1294720B1 (en)	2006-04-05
PL360370A1 (en)	2004-09-06
EP1294720A1 (en)	2003-03-26
WO2001096338A1 (en)	2001-12-20
EA200201255A1 (ru)	2003-06-26
CN1436189A (zh)	2003-08-13
CA2411766A1 (en)	2001-12-20
MY130375A (en)	2007-06-29
UY26767A1 (es)	2002-01-31
PE20020083A1 (es)	2002-02-28
BG107348A (bg)	2004-06-30
EE200200690A (et)	2004-06-15
DK1294720T3 (da)	2006-07-31
SK17722002A3 (sk)	2003-06-03
PT1294720E (pt)	2006-06-30
AR028958A1 (es)	2003-05-28
HK1057558A1 (en)	2004-04-08
JP3923894B2 (ja)	2007-06-06
JP2004502787A (ja)	2004-01-29
AU2001270370B2 (en)	2006-08-03
IL152819A0 (en)	2003-06-24
UA74834C2 (en)	2006-02-15
NO20025844D0 (no)	2002-12-05
DE60118560T2 (de)	2006-09-28
US20020028807A1 (en)	2002-03-07
DE60118560D1 (de)	2006-05-18

Publication	Publication Date	Title
MXPA02012205A (es)	2003-09-10	Inhibidores de transcriptasa inversa no nucleosidos.
PT1585739E (pt)	2011-05-13	Arilciclopropilacetamidas substitu?das como activadores da glucocinase
AR077416A2 (es)	2011-08-24	Compuesto polimorfo estable de flibanserina , procedimiento industrial para su preparacion y uso del mismo para preparar medicamentos
NO20045152L (no)	2005-01-24	Ikke-nukleosid-reverstranskriptaseinhibitorer
EP1354880A4 (en)	2004-08-25	HALOGEN COMPOUNDS HAVING AGONISM TOWARDS THROMBOPOIETIN RECEPTOR
JO2035B1 (en)	1999-05-15	Pyrazine compounds
WO2008005519A3 (en)	2008-04-24	Novel pyridazine compound and use thereof
CA2495721A1 (en)	2004-10-07	Non-nucleoside reverse transcriptase inhibitors
NO931366D0 (no)	1993-04-14	1,2,4-oksadiazolylfenoksyalkylisoksazoler og deres anvendelse som antivirale midler
SE9802974D0 (sv)	1998-09-03	New crystalline forms
MX2021011286A (es)	2022-01-24	Compuestos de heterociclil(fenil)metanol útiles en el tratamiento de la hiperglucemia.
RS50781B (sr)	2010-08-31	Derivati pirido (2,3-d) pirimidina, njihovo dobijanje, njihova primena u terapiji
WO2002024663A3 (en)	2003-10-09	Pyrimidine compounds and their use
WO2003035620A1 (fr)	2003-05-01	Compose bicyclique
RS50229B (sr)	2009-07-15	Analozi vitamina d3
AU572660B2 (en)	1988-05-12	Bis (4-aminophenyl) sulfones
SE0201658D0 (sv)	2002-05-31	Immediate release pharmaceutical formulation
DE60005689D1 (de)	2003-11-06	Neue aminobenzophenone
TW200616933A (en)	2006-06-01	Benzoic acid derivatives as non-nucleoside reverse transcriptase inhibitors
IL145449A0 (en)	2002-06-30	Processes for preparing pesticidal intermediates
MXPA03007966A (es)	2004-05-24	Inhibidores de transcriptasa reversa sin nucleosido.
TR200100070A2 (tr)	2001-08-21	Bileşim
TW198680B (es)	1993-01-21
WO2007002368A3 (en)	2007-05-03	Non-nucleoside reverse transcriptase inhibitors
WO2000056736A3 (en)	2001-04-05	Use of non-nucleoside reverse transcriptase inhibitor (mni) for the treatment of hiv infection

Legal Events

Date	Code	Title	Description
2005-12-08	FG	Grant or registration